<DOC>
	<DOC>NCT00350155</DOC>
	<brief_summary>This study is designed to investigate the potential differences in GI safety and tolerability in the small bowel between lumiracoxib, conventional non-selective NSAID (naproxen) with a proton pump inhibitor (omeprazole), or placebo.</brief_summary>
	<brief_title>Video Capsule Endoscopy to Investigate the Safety and Tolerability of Lumiracoxib in the Small Bowel</brief_title>
	<detailed_description />
	<mesh_term>Omeprazole</mesh_term>
	<mesh_term>Naproxen</mesh_term>
	<mesh_term>Lumiracoxib</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<criteria>Healthy male or female subjects Evidence of cardiovascular, hepatic, gastrointestinal or renal disorders Hereditary problems of galactose intolerance, a severe lactase deficiency or glucosegalactose malabsorption syndrome Smokers Other protocoldefined inclusion/exclusion criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>Video capsule endoscopy, healthy volunteers, naproxen, omeprazole, lumiracoxib, small bowel</keyword>
</DOC>